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Abstract.  [3H]Retinoic acid (RA) and [3H]retinol bind 
in an unsaturable manner to isolated nuclei from 
Nulli-SCC1  and PCC4.azalR embryonal carcinoma 
(EC) cells. When nuclei are challenged with the same 
labeled retinoids on their respective binding proteins 
(CRABP and CRBP), much less binding is observed 
and the binding is saturable. RA-CRABP does not 
compete with [3H]retinol-CRBP  for binding to specific 
Nulli-SCC1  nuclear sites,  whereas retinol-CRBP (but 
not apo-CRBP) actually potentiates the binding of 
[3H]RA-CRABP  to these nuclei. The binding of 
[3H]RA-CRABP  and [3H]retinol-CRBP  is not dramati- 
cally affected by prior removal  of the outer nuclear 
membrane with Triton X-100. However,  treatment with 
the detergent after the binding reaction is complete re- 
moves about half of the bound [3H]RA-CRABP  and al- 
most all of the bound [3H]retinol-CRBP. 
We measured specific  retinoid-binding activities in 
nucleoplasmic extracts  of Nulli-SCC1  and PCC4.azalR 
cells. The only readily detectable specific binding ac- 
tivity in nucleoplasmic extracts  from untreated cells 
was for [3H]retinol in PCC4.azalR preparations. 
Nucleoplasmic extracts from Nulli-SCC1  and 
PCC4.azalR cells pretreated with RA had considerable 
levels of specific  [3H]RA-binding activity with little or 
no increase in [3H]retinol binding. By contrast, similar 
extracts from NulIi-SCC1  cells treated with retinol 
bound large amounts of both [3H]retinol and [3H]RA. 
Under the same conditions, PCC4.azalR extracts also 
contained [3H]RA-binding activity with no increase in 
[3H]retinol binding above the high endogenous levels. 
Although these results might reflect translocation of 
binding proteins from cytoplasm to nucleus, other in- 
terpretations must be considered since we often ob- 
served an increase, rather than the expected reduction, 
in cytoplasmic retinoid-binding protein levels. 
S 
EVERAL studies  support  the  view  that  retinoic  acid 
(RA) t promotion of differentiation of embryonai car- 
cinoma (EC) cells is mediated by cellular RA-binding 
protein (CRABP) (Jetten and Jetten,  1979; Sherman et al., 
1983a; Schindler et al., 1981; McCue et al., 1983, 1984a, b; 
Wang and Gudas, 1984). Evidence has been presented from 
studies with [3H]RA that the RA-CRABP holoprotein inter- 
acts specifically with nuclei in vivo (Wiggert et ai., 1977; Jet- 
ten and Jetten,  1979) and Bok et al.  (1984) have detected 
CRABP  with specific antiserum  in  nuclei  of freshly  dis- 
sected retinal cells. Mehta et al. (1982), Cope et al. (1984a), 
and Takase et al.  (1986) have described  the interaction  in 
vitro between CRABP holoprotein  and nuclei from mam- 
mary carcinoma and testicular cells. In an abstract McCor- 
mick et al. (1984) stated that nuclei from F9 EC cells could 
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1. Abbreviations  used in this paper:  CRABP, cellular retinoic acid-binding 
protein; CRBP, cellular retinol-binding protein; EC, embryonal carcinoma; 
RA, all-trans-retinoic acid; TKDM, 50 mM Tris HC1 pH 7.5, 25 mM KCI, 
0.5 mM DTT, 4 mM MnClz; TPN25, 25 mM Tris HCI pH 7.5, 25 mM 
NaH2PO4, 25 mM NaCI. 
also  bind  [3H]RA-CRABE In this  study, we have under- 
taken further characterization of  the interaction between RA- 
CRABP and EC cell nuclei. Because RA can promote differ- 
entiation of  HL-60 promyelocytic leukemia cells even though 
these cells have little or no CRABP (Douer  and Koetfier, 
1982), and because Chou et ai. (1983) have claimed that RA 
interacts specifically with HL-60 nuclear  components,  we 
have also  examined  the  interaction  of free  RA  with  EC 
nuclei. 
Retinol promotes differentiation of some EC cells but it is 
substantially  less  potent  than  RA  (Eglitis  and  Sherman, 
1983; Jetten and De Luca, 1983). In addition to CRABP, EC 
cells possess CRBP, a binding protein for retinol (Matthaei 
et ai., 1983). Chytil and his colleagues (Takase et al., 1979; 
Liau et al.,  1981) and Cope et al.  (1984a) have thoroughly 
described the interaction between retinol-CRBP and nuclei 
from  rat  testis  and  liver. Liau  et  al.  (1981, 1985) have 
provided evidence that the retinol-CRBP complex interacts 
specifically with chromatin  components  and  that  at some 
point the complex dissociates, leaving the ligand, but not the 
apoprotein,  tightly adherent to some nuclear site(s).  Since 
both  RA  and retinol  might, therefore,  be translocated  to 
nuclei via their binding proteins, we have compared the in- 
teraction between RA-CRABP and retinol-CRBP  with EC 
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binding characteristics could explain the marked margin of 
potency between retinol and RA as inducers of differenti- 
ation. 
Materials and Methods 
Cell Cultures 
Nulli-SCC1  and PCC4.azalR are EC cell lines that differentiate readily in 
response to RA (Jetten et al., 1979). Nulli-SCC1  cells differentiate to a mod- 
est extent in  response to  retinol,  whereas this  retinoid  fails to  induce 
differentiation of PCC4.azalR cells and is toxic to the cells during treatment 
for more than a few days at concentrations at or above 8  x  10  -7 M (Eglitis 
and Sherman,  1983). Cells were maintained in DME supplemented with 
10%  heat-inactivated FCS, extra glucose and glutamine, and antibiotics; 
Nulli-SCC1  cells were cultured on gelatin-coated substrata (see Jetten et al., 
1979 for further details of the characteristics and culture conditions of these 
cells). To obtain nuclei for in vitro retinoid-binding protein assays, cells 
were cultured in 600-cm  2 Nunclon plates (Gibco, Grand Island, NY) and 
harvested when the cell density reached 5  x  107-3  x  l0  s per plate. To 
evaluate  the effects of retinoids on nuclear retinoid-binding activity,  cells 
were cultured for at least 5 d in medium containing 10% FCS delipidated 
with diisopropyl ether (Chain and Knowles, 1976). We have previously de- 
termined that this procedure removes at least 95 % of added labeled retinol 
or RA (Sherman et al., 1983a).  Retinoids were added to the culture medium 
at 2  x  l0  -a M in 0.1% ethanol 2 h before harvesting the cells. Control cul- 
tures were treated with ethanol alone. 
Preparation of  Nuclei 
Nuclei were isolated by the method of Liau et al. (1981). Briefly, cells were 
washed with PBS, trypsinized, collected by low speed centrifugation, and 
washed once more with cold buffered saline. All subsequent procedures 
were carried out at 4°C and in the presence of 0.25  ~tM phenylmethylsul- 
fonylfluoride to minimize protein degradation. Cells were homogenized in 
0.87 M sucrose in TKDM (50 mM "Iris HCI pH 7.5, 25 mM KCI, 0.5 mM 
DTT,  and 4 mM MnCI2) and centrifuged at 12,000 g for 30 rain. The su- 
pernate was centrifuged at 105,000 g for 90 rain and extensively dialyzed 
against TPN25  (25  mM Tris  HCI  pH  7.5, 25  rnM NaH2PO4,  25  mM 
NaC1)  to  yield the  cytosol  fraction.  The  12,000  g  nuclear  pellet  was 
resuspended by gentle homogenization in 0.87 M sucrose in TKDM, and 
centrifuged at 95,000 g for 75 rain in a swinging bucket rotor (model SW28; 
Beckman Instruments, Inc., Palo Alto, CA) between a pad of 2 M sucrose 
and an overlay of 0.3  M  sucrose, both in TKDM buffer.  The pellet was 
resuspended in 1.8 M sucrose in TKDM, centrifuged at 18,000 g for 30 rain, 
and washed with 0.3 M sucrose in TKDM. For in vitro studies, the resultant 
purified nuclei were resuspended in 0.3 M sucrose in TKDM and used im- 
mediately.  For  determination of intrinsic  retinoid-binding activity,  the 
nuclei were centrifuged at 800 g  for 10 rain, resuspended in TPN25, and 
frozen. After thawing, the extracts were sonicated for 3 rain and centrifuged 
at 147,000 g  for 90 rain (model SWS0 rotor; Beckman Instruments, Inc.) 
to generate nucleosolic extracts. 
The purity of isolated nuclei was confirmed by light and electron mi- 
croscopy. 
Preparation of  Retinoid-binding  Proteins 
Tumor tissue generated in mice by the injection of PCC4.azalR EC cells 
(106 cells per mouse) served as a source of retinoid-binding proteins. The 
procedure used was based upon that described by Ong and Chytil (1980). 
Pooled tumor tissue (250-300 g) was homogenized in 2 vol of 50 mM Hepes 
buffer,  pH 7.5. The homogenate was cleared by centrifugation for 30 min 
at 30,000 g. The supernate was brought to pH 5.0 by dropwise addition of 
glacial acetic acid, centrifuged, and the resultant supernate was readjusted 
to pH 7.5 with 1 N NaOH. A 40-75 % ammonium sulphate cut was obtained 
and dialyzed against 50 mM Tris, pH 7.5, plus 200 mM NaCI. 10 lxCi each 
of [3H]RA and [3H]retinol  (both at 20-30 Ci/mmol) were added and the 
preparation was kept overnight at 4°C. The labeled material was then ap- 
plied to a Sephadex G-75 column (12  x  75 cm) and eluted with the same 
buffer.  The two retinoid-binding proteins coeluted between 880 and 1,070 
ml. After regeneration of apoproteins by exposure to fluorescent light (5 h 
at 4°C), the crude binding protein preparation was dialyzed against 25 mM 
Tris,  pH  Z5,  plus  25  mM  NaC1,  labeled  again  with  5  gCi  each  of 
[3H]retinol  and  [3H]RA,  and applied to a  Bio-Gel HTP hydroxylapatite 
column (2.5  ×  40 cm). The column was eluted with a gradient of 0-120 
mM sodium phosphate in the same buffer. This chromatographic procedure 
successfully separated the two binding proteins, as could be demonstrated 
by light inactivating the bound retinoids and, after dialysis, recharging with 
either [3H]retinol  or [3H]RA.  CRBP activity was eluted at 70 mM phos- 
phate whereas CRABP activity was recovered at 90 mM phosphate. As 
demonstrated in Table I, no cross-binding  of  labeled retinoids was observed. 
The CRBP and CRABP preparations were dialyzed against TPN25, concen- 
trated to ,,ol mg/ml, and stored at -70°C. When the binding protein prepara- 
tions were analyzed by SDS PAGE, both contained prominent peaks at ,-ol5 
kD as expected. Unidentified bands were observed at ~20 and 30 kD (not 
shown); the latter might represent dimerized binding protein. Subsequent 
purification  steps were  not  implemented because the partially  purified 
preparations showed complete discrimination of ligand binding and because 
attempts to further purify the proteins (e.g., by HPLC) resulted in prepara- 
tions that had little or no capacity for holoprotein regeneration after ligand 
was removed by exposure to light. For final charging, the binding proteins 
(1.5 rag) were incubated in 9 ml of TPN25 in the presence of 200 gCi of 
the appropriate [3H]retinoid  or 0.1 lunol unlabeled retinoid. After incuba- 
tion overnight at 4°C, 1 ml of dextran-coated charcoal (20 mg charcoal and 
2 mg dextran-T-70 per ml TPN25) was added, and the solutions were mixed 
and centrifuged at 1,500 g for 20 min. The supernates were dialyzed in the 
cold  against  TPN25.  The  resultant  specific  activities  of  the  labeled 
holoproteins were in the range of 1.5-3.0  ×  107 dpm/mg protein. 
Association of [3H]Retinoid-binding Proteins 
with Nuclei 
Freshly isolated nuclei were incubated at 20°C for 2 h in an assay mixture 
(1.25 ml) containing TPN25 plus 250 mM sucrose and 0.5-1  ×  106 dpm 
of [3H]retinoid  holo-binding protein. Unlabeled retinoid holo-bindiag pro- 
teins were added at the indicated molar ratios. At the end of the incubation 
period, nuclei complexed with [3H]retinol-CRBP were trapped on GVWP 
hydrophilic filters (0.22  Ilm; Millipore/Continental Water Systems, Bed- 
ford, MA) and washed twice with 10 ml cold PBS. Nuclei complexed with 
[3H]RA-CRABP were collected on cellulose acetate filters (Metricel mem- 
brane GA-G; Gelman Services, Inc., Ann Arbor, MI) and similarly washed. 
These conditions were found to produce the lowest background values (,x,1% 
for [3H]retinol-CRBP and <4% for [3H]RA-CRABP). The filters were air 
dried and counted. 
Binding Protein Measurements 
Retinoid-binding protein contents were measured by a procedure adapted 
from a combination of a previously published Sephadex assay (Sherman et 
al., 1983a) and a method used for measuring progesterone receptor (Barkai 
et al.,  1981). Samples containing 50-200  Ixg of protein in TPN25 buffer 
were pipetted onto the disk from a Tetralute kit (Ames-Yissum Ltd., Jerusa- 
lem, Israel) that was placed on top of a 1 x  2 cm Sephadex G-25 column. 
For CRABP measurements [3H]RA (3-4  x  105 cpm; 20-30 Ci/mmol), in 
the absence or presence of a  100-fold molar excess of unlabeled RA, was 
added in 10 I11 ethanol. The reaction, in a total volume of  300 gl, was carded 
out for 90 min at 4°C. Column outlets were then opened, the void volume 
drained, and the bound fraction eluted with 1 ml of TPN25 directly into 
minivials. CRBP was assayed in the same way except that the labeled reti- 
noid was [3H]retinol  and 0.3 M sucrose was included in the assay mixture 
Table I. Retinoid-binding Specificity of  Partially Purified 
CRABP and CRBP Preparations* 
Binding protein  Specific [3H]RA  Specific [3H]retinol 
preparation  binding  binding 
CRABP  43,240  +  1,110  240  +  140 
CRBP  900  +  900  46,110  4-  1,130 
*  Binding-protein  preparations  were generated  as described in Materials  and 
Methods. After separation  by BioGel HTP hydroxylapatite  chromatography, 
25  I~g  protein  from  each  preparation  was  challenged with  the  indicated 
[3H]retinoid without and with a 100-fold molar excess of the homologous un- 
labeled  retinoid.  Assay  conditions  and  procedures for  measuring  specific 
binding-protein  activities  are provided in Materials  and Methods. Data  are 
averaged  from  four independent  measurements  and  are  expressed as cpm 
+  SEM. 
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pairs (i.e., with and without unlabeled retinoid). Sephadex columns were 
regenerated by washing sequentially with 0.1 N HCI, distilled water, 0.1 N 
NaOH, distilled water, and TPN25. 
This assay procedure was reproducible and sensitive. Variation among 
triplicates was on the order of 10 % and day-to-day reproducibility was excel- 
lent. Incubation on the disks instead of in tubes did not result in increased 
amounts of [3H]retinoid  binding but led to accelerated reaction rates. The 
use of fewer counts per minute of labeled retinoid (about one-fifth that in 
previous studies; e.g., Sherman et al., 1983a) reduced background, thus ob- 
viating the need for dextran-charcoal treatment that can lead to displace- 
ment of labeled retinoid from its binding protein (unpublished results). As 
a result, we consistently obtained binding protein specific activities 5-10- 
fold greater than those observed previously (e.g., Matthaei et al.,  1983). 
To  measure retinoid-binding activities in nuclei and cytosols of cells 
pretreated with retinoids, extracts were maintained at 4°C under fluorescent 
light for 7  h.  In previous studies with both crude and purified retinoid- 
binding proteins, we determined that these conditions were sufficient to re- 
move all previously bound  [3H]retinol  or [3H]RA  from their respective 
binding protein without detectable loss of  binding activity when the samples 
were rechallenged with appropriate [3H]retinoid.  Specific retinoid-binding 
activities were then determined as described above. 
Results 
Characterization of the Association of  Retinoid- 
binding Proteins with Nuclei 
Binding  of  [3H]RA-CRABP  to  PCC4.a~IR  and  Nulli- 
SCC1 nuclei was maximal after 30 rain at 20°C and was sta- 
ble for at least 2 h. Specific binding of [3H]retinol-CRBP to 
the same nuclei appeared to be slower, reaching a maximum 
by 2  h.  Specific binding was linear in the range of 1-3  x 
106 nuclei per assay. In subsequent studies we used 2  x  106 
nuclei per assay and an incubation period of 2 h at room tem- 
perature, 
As reported previously by us (Sherman et al.,  1985) and 
by others (Takase et al., 1979; Cope et al., 1984a), when iso- 
lated  nuclei  were  incubated  with  [3H]RA  or  [3H]retinol, 
binding was unsaturable.  Although binding was apparently 
nonspecific, nuclei bound more RA than retinol at similar 
concentrations  of retinoid  (Fig.  1 A).  When the same nu- 
clear preparations were incubated with radioactive pH]RA- 
CRABP or [3H]retinol-CRBP, trapped on filters, and exten- 
sively washed, less retinoid was associated with the nuclei 
(inset, Fig. 1 B). Furthermore, under these conditions, bind- 
ing reached a plateau and there was more retinol than RA 
bound.  The amount of radioactive retinoid bound could be 
reduced by including cold homologous holoprotein in the in- 
cubation mixture (Fig.  I  B).  Similar results were obtained 
when PCC4.azalR nuclei were used as targets for both bind- 
ing proteins (not shown). We calculate from our data that the 
total numbers of specific binding sites in or on Nulli-SCC1 
nuclei for RA-CRABP and retinol-CRBP were 1.7 (+0.54) 
x  105 and 2.4 (+0.71)  x  105, respectively. The correspond- 
ing  numbers  for  holo-binding  protein  association  with 
PCC4.azalR nuclei were calculated to be 2.8 (+0.91)  x  105 
and 5.7  (+1.17)  x  105, respectively. 
Effects of Free Ligand on Retinoid Holo-binding 
Protein Association with Nuclei 
Takase et al.  (1979) have reported that free ligand failed to 
compete with  [3H]retinol-CRBP  for specific sites  in  liver 
nuclei,  though data were not presented.  We have extended 
these experiments with EC nuclei to include both retinoids 
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Figure 1. Introduction of free and bound retinoids with Nulli-SCCI 
nuclei. Nuclei (2 ×  106) were prepared and challenged at 25°C for 
2 h with [3H]RA or [3H]retinol either  free (a) or bound to their 
respective binding proteins (b). (a) The assay mixtures contained 
23.7 pM [3H]RA (open circles) or 21.4 pM [3H]retinol (solid cir- 
cles) plus the indicated molar excesses of unlabeled RA or retinol, 
respectively. The curves illustrate the total amount of retinoid (la- 
beled plus unlabeled) bound.  (b) The assay mixture contained 4.4 
pM [3HIRA-CRABP (open circles) or 8.8 pM [3H]retinol-CRBP 
(solid circles) plus the indicated molar excesses of unlabeled ho- 
mologous holo-binding protein.  Data are expressed as percent of 
counts per minute bound relative to that in the absence of unlabeled 
competing holoprotein.  Data from the same experiments are ex- 
pressed in the inset as the amount of total holoprotein bound at each 
input concentration.  Each point in b represents the mean -t- SEM 
of duplicate determinations from at least five independent experi- 
ments. 
and their binding proteins. The results are presented in Fig. 
2. The data illustrate that the heterologous ligand had no ef- 
fect upon holo-binding protein interaction with Nulli-SCC1 
nuclei.  The homologous ligand did not reduce [3H]retinoid 
interaction with nuclei, indicating that free ligand does not 
compete for specific holo-binding protein binding sites.  To 
the contrary, large excesses of the homologous ligands actu- 
ally augmented  the  association of label  with  nuclei.  The 
significance of this observation will be discussed below (see 
Discussion). 
Effects of  Heterologous Retinoid Holo-binding Protein 
on Association with Nuclei 
To determine whether CRBP and CRABP binding sites on 
EC nuclei are shared or unique, we carried out competitive 
binding studies as described in Fig.  1 B except that the unla- 
beled retinoid holo-binding protein was heterologous. Fig. 3 
illustrates  that  the  binding  of [3H]retinol-CRBP to  Nulli- 
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Figure 2.  Effects of free retinoid  on interaction  of retinoid  holo- 
binding  proteins  with  Nulli-SCCl  nuclei.  Binding  experiments 
were carried out as described in Fig.  1 except that where indicated 
unlabeled  free retinoid  was added in the indicated  molar excess. 
Values with  homologous ligand  are shown as the mean  +  SEM 
from triplicate  determinations  in four independent  experiments. 
Values with heterologous ligand are averages of triplicate  determi- 
nations from a single experiment.  (Open circles) [3H]RA-CRABP 
plus RA; (open squares) [3H]RA-CRABP plus retinol;  (solid cir- 
cles) [3H]retinol-CRBP  plus  retinol;  (solid squares) [3H]retinol- 
CRBP plus RA. 
SCC1 nuclei was unaffected by a large molar excess of unla- 
beled RA-CRABP. Since equal amounts of unlabeled retinol- 
CRBP markedly reduced [3H]retinol-CRBP association with 
nuclei (Fig.  1 B), it can be concluded that RA-CRABP can- 
not  effectively  compete  for  retinol-CRBP  sites  on  NulIi- 
SCC1 nuclei. Reciprocal experiments illustrate that retinol- 
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Figure 3. Potentiation of the association  of RA-CRABP with Nulli- 
SCCI nuclei by retinol-CRBP.  Binding studies were carried out as 
described in Fig.  1 b except  that unlabeled  heterologous  retinoid 
holo-binding  proteins were used as competitors in molar excess as 
indicated. (Open circles) [3HIRA-CRABP plus retinol-CRBP;  (sol- 
id circles) [3H]retinol-CRBP  plus  RA-CRABE Data are pooled 
from duplicate  determinations  in at least two independent  experi- 
ments. 
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Figure 4. Comparison  of effects of  apo-CRBP  vs. retinol-CRBP  on 
the interaction  of [3H]RA-CRABP with NulIi-SCC1 nuclei.  Bind- 
ing studies were carried out as described in Fig.  1 b except that the 
interaction  of [3H]RA-CRABP  with  nuclei was measured in the 
presence of retinol-CRBP (open circles) or apo-CRBP (solid cir- 
cles) at the indicated  molar excess. Data are averaged from tripli- 
cate determinations. 
CRBP not only failed to reduce [3H]RA-CRABP binding to 
nuclei but actually potentiated the interaction (Fig. 3). Quali- 
tatively, this potentiation was reproducibly observed in sev- 
eral independent experiments. The extent of increase in label 
associated with nuclei varied from three- to ninefold. Similar 
potentiation  was  observed  with  nuclei  from  PCC4.azalR 
cells (not shown). The data in Fig. 4 illustrate that the poten- 
tiation could be elicited by the retinol holo-binding protein, 
but not by the apoprotein. As mentioned above and demon- 
strated in Fig. 2, free retinol failed to influence the interac- 
tion of [3H]RA-CRABP with nuclei; neither was there any 
Table II. Effects of Triton X-IO0 upon the Interaction 
of Holo-retinoid-binding Proteins with Nuclei* 
Counts per minute bound 
Time of Triton-X 
Binding protein  treatment  Nulli-SCC1  PCC4.azalR 
%  % 
[3H]RetinoI-CRBP  None  100  100 
Before binding  83  +  13.2 
After binding  19  +  6.8  4  +  1.4 
[3H]RA-CRABP  None  100  100 
Before binding  109  +  7.6 
After binding  52  +  2.9  66  +  4.2 
[3H]RA-CRABP  +  None  219  +  9.2* 
retinol-CRBP  Before binding  107  +  3.3* 
After binding  125  +  3.8* 
* EC  nuclei (2  x  106) were preincubated  for 30  rain at  room temperature 
without or with 0.4% Triton X-100 in TKDM buffer plus 0.3 M sucrose. They 
were washed by centrifugation in the same buffer and incubated for 2 h at 25°C 
with 6  x  104 cpm [3H]retinol-CRBP, 3  x  104 cpm [3HIRA-CRABP, or 3  x 
104 cpm [3H]RA-CRABP plus a fivefold molar excess of retinol-CRBP.  The 
nuclei were then trapped  on filters (see Materials and Methods) and washed 
either with three  10-ml vol of PBS or, as indicated, 2 vol of saline plus 0.4% 
Triton X-100. Values are expressed as percent of radioactivity relative to that 
associated with nuclei challenged with [3H]retinol or 13HIRA-CRABP without 
added  unlabeled  holoprotein  or  detergent  (6-7  x  103  cpm  for  Nulli  EC 
nuclei,  10-11  ×  103 cpm for PCC4.azalR  nuclei). Values are averaged from 
triplicate  determinations  in  two  independent  experiments  for  [3H]retinol- 
CRBP and [3H]RA-CRABP binding to Nulli-SCCl  nuclei, and from triplicate 
determinations in a single experiment for [3H]RA-CRABP plus retinol-CRBP 
binding to Nulli-SCCl  nuclei and for binding assays with PCC4.azalR  nuclei. 
* Values  are  relative  to  those  obtained  simultaneously  for 13HIRA-CRABP 
binding to nuclei in the absence of detergent treatment or retinol-CRBP. 
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min (not shown). 
Effects of Triton X-IO0 on Retinoid Holo-binding 
Protein Interaction with Nuclei 
Treatment of isolated nuclei with 0.25-0.5 % Triton X-100 re- 
moves the outer nuclear membrane and a substantial propor- 
tion of nuclear phospholipids (e.g.,  Knowles et al.,  1973; 
Liau et al.,  1981). Liau et al. (1981) have demonstrated that 
such treatment does not dramatically reduce retinol-CRBP 
interaction with liver nuclei. We studied the effects of Triton 
X-100 on the association of [3H]retinol-CRBP and [3H]RA- 
CRABP with Nulli-SCC1 and PCC4.azalR nuclei. Table II 
illustrates that Triton X-100-treated nuclei specifically bound 
both [3H]RA-CRABP and [3H]retinol-CRBP at levels simi- 
lar to that of untreated  nuclei.  On  the other hand,  when 
nuclei  were  first  challenged  with  holo-binding  proteins, 
trapped on filters, and then treated with the same concentra- 
tion of detergent during washing, about half of the [3H]RA 
and almost all of the [3H]retinol were displaced (Table II). 
An initial series of studies suggested that pretreatment of nu- 
clei with Triton X-100 prevented the potentiation of [3H]RA- 
CRABP by retinol-CRBP, but that once this potentiation had 
occurred, the stability of the extra [3H]RA-CRABP bound 
was  as  resistant  to  detergent treatment as  basal  [3H]RA- 
CRABP binding (Table II). 
Effects of  Retinoid Treatment of  Intact Cells upon 
Nuclear and Cytosolic Retinoid-binding Activities 
It has been shown that a 2-h exposure is adequate for move- 
ment of [3H]RA  or  [3H]retinol into  the  nuclear compart- 
ment in EC cells (Jetten and Jetten,  1979; Sherman et al., 
1985).  To evaluate the effects of exposing cells to retinoids 
upon specific retinoid-binding activities, we cultured Nulli- 
SCC1  or PCC4.azalR cells for 5 d or more in medium de- 
pleted of retinoids  and  then treated  them  with  unlabeled 
retinol or RA for 2 or 5 h. We collected and fractionated the 
cells and tested cytosolic and nucleosolic extracts for specific 
retinoid-binding activities. To do this, we exposed the cellu- 
lar fractions to light under conditions that strip retinoids 
from their binding protein sites and then incubated aliquots 
of the extracts with [3H]RA or [3H]retinol with or without 
a large molar excess of the homologous unlabeled retinoid. 
As the data in Table III illustrate, nucleosolic preparations 
from untreated Nulli-SCC1 cells contained little if any spe- 
cific RA- or retinol-binding activity. After 2-h exposure of 
these cells to RA, there was a large (more than 20-fold) in- 
crease in specific RA-binding capacity in the nucleosolic ex- 
tracts. After the cells were treated with retinol, the specific 
binding of retinol by nucleosols was elevated by more than 
40-fold (Table III). There was, however, a notable difference 
between the effects of RA and retinol pretreatment on heter- 
ologous specific binding activity in nucleosolic extracts: RA 
had  only minimal  effects (not  statistically  significant)  on 
retinol-binding capacity, whereas  nucleosols from retinol- 
treated cells possessed considerably increased RA-binding 
activity (Table HI). The same qualitative patterns were ob- 
served after cells were preincubated with retinoids for 5 h 
except that the amount of increase in specific binding activi- 
ties was in every instance lower than that observed after 2 h 
retinoid pretreatments (Table HI). Subnuclear fractions other 
than the nucleosol were found to possess little or no specific 
retinoid-binding activity, with or without retinoid pretreat- 
ment of the intact cells (not shown). 
The above experiments were repeated with PCC4.azalR 
cells (Table IV). RA pretreatments affected RA-binding ac- 
tivities in PCC4.azalR nucleosolic extracts in the same way 
as those in Nulli-SCC1  preparations. The specific retinol- 
binding  ability  of PCC4.azalR  nucleosols  was  markedly 
different from that of Nulli-SCC1  nucleosols:  the  former 
preparations  contained readily detectable,  and  essentially 
unchanged, binding capacities regardless of the retinoid con- 
tent of the medium in the 2- or 5-h period before collection 
of the cells (Table IV). Despite the lack of effect of retinol 
pretreatment  on  retinol-binding  activity  in  PCC4.azalR 
nucleosols, specific RA binding was markedly elevated in re- 
sponse to retinol. 
In a series of experiments, we attempted to characterize 
this specific nucleosolic binding of [3H]RA by sucrose den- 
sity gradient centrifugation. We consistently observed a het- 
erodisperse radioactivity profile; although there was a clear 
labeled peak in the 2S region of the gradient, as would be 
expected for the [3H]RA-CRABP complex, radioactive ma- 
terial  also  cosedimented  with  faster moving components. 
There was  no obvious qualitative difference in  the  radio- 
activity profiles from extracts of cells pretreated with unla- 
beled RA or retinol (data not shown). 
Table III. Binding Activities in Cytosolic and Nucleosolic Extracts of  Retinoid-depleted Nulli-SCC1 Cells 
Following Exposure to Retinoids* 
Retinoid pretreatment 
Retinol  Retinoic acid 
Cell  Binding 
extract  activity  None  2 h  5 h  2 h  5 h 
Nucleosol  Retinol  0.04  +  0.02  (20)  1.88  +  0.38  (11)*  1.35  +  0.25  (9)*  0.13  +  0.09  (8)  0.09  +  0.06  (9) 
RA  0.07  +  0.03  (22)  0.95  +  0.20  (8)~  0.78  +  0.14  (12)~  1.55  5:0.15  (16)5  1.29  +  0.15  (11)~ 
Cytosol  Retinol  5.8  +  0.50  (5)  7.2  +  0.50  (5)§  8.4  +  0.19  (3)11  5.1  5:0.26  (3)  9.0  +  0.67  (3)§ 
RA  8.0  5-  1.42  (3)  9.7  +  0.69  (3)  17,2  +  1.26  (3)11  15.7  ±  2.58  (3)§  12.9  ±  0.42  (3)§ 
* NulIi-SCC1 cells were cultured for 5 or more days in medium with delipidated serum and then exposed to unlabeled retinol or RA (2  ×  10  -6 M) for the indi- 
cated times.  Cells were collected,  fractionated,  exposed to light,  and specific retinoid-binding activities were measured (see Materials and Methods).  Data are 
presented as the mean :t:  SEM in picomoles retinoid bound per milligram extract protein.  Numbers in parentheses refer to the number of independent samples. 
~: Values were significantly different (P <  0.001)  from those obtained with nucleosolic extracts  from control  (no pretreatment)  cells. 
§ Values differed (P <  0.05)  from those obtained with cytosolic extracts from control cells. 
II Values were significantly different (P <  0.01)  from those obtained with cytosolic extracts  from control cells. 
Barkai and Sherman Retinoid-binding  Protein  Interaction  with Nuclei  675 Table IV. Retinoid-binding Activities in Cytosolic and Nucleosolic Extracts of  Retinoid-depleted PCC4.azal R 
Cells after Exposure to Retinoids* 
Retinoid pretreatment 
Retinol  Retinoic  acid 
Cell  Binding 
extract  activity  None  2 h  5 h  2 h  5 h 
Nucleosol  Retinol  0.58  +  0.09  (17)  0.57  +  0.04 (6)  0.58  +  0.05  (9)  ND  0.69  +  0.14 (11) 
RA  0.07  +  0.06 (13)  0.53  +  0.06 (9)*  0.74  +  0.09  (8)~  1.51  +  0.25 (6)*  0.71  +  0.14 (6)~ 
Cytosol  Retinol  4.2  +  0.26  (6)  6.3  +  0.74 (6)§  4.9  5:0.25  (5)  5.5  5:0.61  (3)  4.4  5:0.20  (3) 
RA  13.9  5:0.96  (6)  13.9  5:1.35  (3)  10.1  5:0.91  (3)§  17.4  5:1.22  (4)§  11.7  -t- 0.28  (3) 
* PCC4.azalR cells were cultured for 5 or more days in medium with delipidated  serum and then exposed to unlabeled retinol  or RA (2 x  10  -6 M) for the indi- 
cated times. Cells were collected,  fractionated, exposed to light, and specific  retinoid-binding activities  were measured (see Materials and Methods). Data are 
presented as the mean +  SEM in picomoles retinoid bound per milligram extract protein.  Numbers in parentheses refer to the number of independent assays. 
Values were significantly different  (P <  0.001) from those obtained with nucleosolic extracts from control (no pretreatment cells). 
§ Values differed  (P <  0.05) from those obtained with cytosolic extracts from control cells. 
We also measured binding capacities in cytosolic fractions 
of the ceils. We observed that RA and retinol pretreatment 
of Nulli-SCC1 cells resulted in increased cytosolic levels of 
their respective binding proteins. In fact cells exposed for 5 h 
with either retinoid possessed significantly elevated levels of 
both retinoid-binding protein activities (Table III). Some in- 
creases in retinoid-binding protein levels were also observed 
with cytosolic extracts of PCC4.azalR cells, albeit not so 
consistently as with Nulli-SCC1 cells (Table IV). 
Discussion 
The experiments described here illustrate that both RA and 
retinol bind specifically to EC nuclei when introduced via 
their binding proteins. This finding and our estimates of the 
number of specific binding sites (1-3  ×  105 per nucleus) are 
consistent with previous reports (Takase et al.,  1979; Liau et 
al.,  1981; Cope et al.,  1984a;  Mehta et al.,  1982;  McCor- 
mick et al., 1984). Since free retinoids do not show specific, 
saturable binding to EC nuclei (Fig.  1 A; see also Takase et 
al.,  1979; McCormick et al.,  1984;  Sherman et al.,  1985), 
it is logical to conclude that free and holoprotein-bound reti- 
noids do not compete for the same nuclear sites. Fig. 2 illus- 
trates that when the labeled ligand on the holoprotein and the 
competing free retinoid are the same, there is actually an in- 
crease in the amount of radioactivity bound to EC nuclei. A 
likely explanation is that the unlabeled retinoid can exchange 
with labeled retinoid on its holoprotein, allowing the freed, 
labeled retinoid to bind nonspecifically to nuclei in an un- 
saturable manner. This would explain why excess RA has a 
substantially greater effect upon displaced [3H]RA  binding 
to nuclei than does unlabeled retinol upon displaced [3H]- 
retinol binding  (Fig.  2),  since free [3H]RA  has a  greater 
affinity for nuclei than does free [3H]retinol (Fig.  1 A). 
Pretreatment of liver nuclei with Triton X-100 removed 
<30% of the specific retinol-CRBP binding sites, indicating 
that  binding-protein-mediated  interaction  of retinol  with 
these nuclei was unlikely to involve phospholipid or the outer 
nuclear membrane (Liau et al.,  1981). Our data (Table II) 
confirm this result and extend it to [3H]RA delivered to EC 
nuclei via its binding protein. The consequence of exposure 
of nuclei to Triton X-100 after interaction with [3H]retinol- 
CRBP was strikingly different, since most of the label was 
solubilized.  The  complex  between  [3H]RA-CRABP  and 
nuclei was consistently more refractory to subsequent deter- 
gent  treatment.  Since  the  two  holoproteins  have  similar 
affinities for untreated nuclei (Fig.  1 B), these results could 
reflect a different type of nuclear binding site for the two 
holoprotein-bound retinoids. 
We have found that the two holoproteins fail to compete 
for the same nuclear sites, adding to the view (Takase et al., 
1979; Cope et al., 1984a) that these specific binding sites are 
different. However, ours is the first observation that retinol- 
CRBP actually potentiates the binding of [3H]RA-CRABP 
to nuclei. It is unlikely that the phenomenon we have ob- 
served has a trivial explanation, e.g., contamination of the 
retinol preparation with RA, since only holo-CRBP, not free 
retinol or apo-CRBP, elicits the potentiation. The elimina- 
tion  of  the  potentiation  of  [3H]RA-CRABP  binding  by 
pretreatment of EC nuclei with Triton X-100 (Table II) sug- 
gests that these binding sites are different from the "basal" 
[3H]RA-CRABP nuclear binding  sites observed in the ab- 
sence of retinol-CRBP. 
The  interactions between  retinoid-binding  proteins  and 
nuclei in vitro, including the potentiation, are paralleled by 
our findings with intact Nulli-SCC1 EC cells: when cells are 
pretreated with RA the nucleosols possess specific binding 
activity, but only for that retinoid; however, when the cells 
are  preincubated with  retinol,  binding  activities  for both 
retinol and RA are readily detected. It must be noted, how- 
ever, that neither in this study nor in previous ones (Wiggert 
et al.,  1977; Jetten and Jetten, 1979) has it been proven that 
the specific retinoid-binding activities in cytosolic and nucle- 
osolic extracts are the same. Indeed, Chou et al. (1983) and 
Cope et al.  (1984b)  have reported the presence of nuclear 
RA-binding proteins whose properties appear to be different 
from that of the well-characterized CRABP.  Such proteins 
might also be present in EC cells and increase in response 
to  retinoid  exposure.  Sucrose  density  gradient  analyses 
failed to clarify this issue since the profiles obtained were 
heterogeneous.  Antisera  specific  for  CRBP  and  CRABP 
(e.g., Adachi et al.,  1981; Ong et al.,  1982; Eriksson et al., 
1984) could ultimately be helpful in characterization of the 
nuclear retinoid-binding activities. 
Translocation of binding  protein  molecules  from cyto- 
plasm to nucleus in response to the uptake of retinoids by the 
cell should be characterized not only by detection of activity 
in nuclear extracts but also by diminution of cytoplasmic ac- 
tivity.  In  fact,  retinoid  treatments  commonly  resulted  in 
modest,  but statistically  significant,  increases in cytosolic 
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in Tables III and IV, we calculate that EC cells possess 2-4 
x  105 molecules each of CRBP and CRABP (similar to that 
reported for CRBP in liver cells by Takase et al. [1979]), and 
that under optimal  conditions only  ~104  specific binding 
sites for [3H]retinol or [3H]RA appear in the nucleosol from 
each cell (in several attempts we found specific retinoid bind- 
ing activity only in this nuclear fraction). The loss of such 
a small proportion of cytoplasmic binding protein molecules 
in response to retinoid uptake could have escaped detection, 
especially if retinoid treatments lead to increased total levels 
of binding proteins. 
The presence of constitutive retinol-binding activity in 
nucleosols from PCC4.azalR cells was unexpected and is un- 
explained.  Unlike  other  EC  lines,  PCC4.azalR  cells  are 
killed by exposure to relatively low levels of retinol (Jetten 
et al.,  1979; Eglitis and Sherman,  1983); we are attempting 
to determine whether these two observations are related. Al- 
though preincubation of PCC4.azalR cells with retinol has 
no effect on nucleosolic retinol-binding activity, it leads to 
the appearance of nucleosolic RA-binding activity, as is seen 
with Nulli-SCC1 nucleosols. Thus the two effects of retinol 
preincubation appear to be separable. 
When incubated for 2 h with 10  -6 M  [3H]RA or [3H]ret- 
inol,  EC  cells  take  up  ~2  ×  107  and  8  x  107  retinoid 
molecules, respectively, and 1-2 % of the label (equivalent to 
r~105-106 retinoid  molecules)  is  detected  in  purified  EC 
nuclei after treatment with Triton X-100  (Sherman et al., 
1983b,  1985, and unpublished observations). It is therefore 
notable that if our in vivo studies (Tables III and IV) are de- 
tecting  translocation  of holo-binding  proteins  from  cyto- 
plasm  to  nucleus,  many  fewer binding  protein molecules 
(,~104) than  ligands  are associated with nuclei at any one 
time.  A  reasonable explanation for this is the proposal by 
Liau et al.  (1981) and Takase et al.  (1986) that the retinoid 
holo-binding proteins shuttle their ligands to appropriate nu- 
clear sites and then the apoproteins return to the cytoplasm. 
However, our data do not eliminate the possibility that reti- 
noids not bound to their binding proteins can also reach the 
nucleus in vivo. 
The indication that retinol-CRBP and RA-CRABP have 
independent nuclear binding sites could explain why RA is 
considerably more potent than retinol in inducing EC cell 
differentiation. We find it unlikely that retinol can be con- 
vened to RA in amounts adequate to explain the potency of 
the former retinoid (Eglitis and Sherman, 1983; Gubler and 
Sherman,  1983)  as  has  been  proposed  by  Williams  and 
Napoli (1985).  However, the observation that retinol-CRBP 
can potentiate interaction of RA-CRABP with EC nuclei and 
that incubation of cells with retinol generates specific nucle- 
osolic binding sites for RA suggests that in the presence of 
retinol very small amounts of RA can become disproportion- 
ately effective. 
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Note Added in Proof.  After this manuscript was submitted, Takase  et al. 
(Takase, S., D. E. Ong, and E  Chytil,  1986, Transfer of retinoic  acid from 
its complex with cellular retinoic  acid-binding  protein to the nucleus, Arch. 
Biochem.  Biophys.,  247:328-334) reported that RA-CRABP bound specif- 
ically to rat testis nuclei.  Contrary to our observations with EC nuclei,  they 
stated that retinol-CRBP  had no effect on the amount of [3H]RA bound to 
the testis  nuclei  when added  as part of the CRABP holoprotein complex. 
The potentiation  that we observed might, therefore,  be cell-type  specific. 
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